跳至主要内容
临床试验/NCT01673711
NCT01673711已完成不适用

Correlation of [D10] Phenanthrene Metabolism With Bronchoepithelial Dysplasia and Metaplasia in Smokers at High Risk for Lung Cancer

University of Minnesota3 个研究点 分布在 2 个国家目标入组 350 人开始时间: 2012年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
350
试验地点
3
主要终点
PheT:HOPhe ratio

研究概览

简要总结

This clinical trial studies deuterated phenanthrene tetraol in smokers who are at high risk for lung cancer. Studying samples of urine in the laboratory from smokers who are at high risk for lung cancer may help doctors learn more about biomarkers related to cancer.

详细描述

PRIMARY OBJECTIVES:

I. To determine the relationship between urinary deuterated ([D10]) phenanthrene tetraol (PheT) level, PheT:phenanthrols (HOPhe) ratio, and the presence of bronchoepithelial metaplasia and/or dysplasia in smokers who have undergone screening bronchoscopy at Roswell Park Cancer Institute (RPCI).

OUTLINE:

Patients receive deuterated phenanthrene tetraol orally (PO). Urine samples are collected for laboratory studies for 6 hours after dosing.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Basic Science (deuterated phenanthrene tetraol)

Patients receive deuterated phenanthrene tetraol PO and collect urine for 6 hours after dosing.

干预措施: deuterated phenanthrene tetraol (Drug)

Basic Science (deuterated phenanthrene tetraol)

Patients receive deuterated phenanthrene tetraol PO and collect urine for 6 hours after dosing.

干预措施: pharmacological study (Drug)

Basic Science (deuterated phenanthrene tetraol)

Patients receive deuterated phenanthrene tetraol PO and collect urine for 6 hours after dosing.

干预措施: laboratory biomarker analysis (Drug)

结局指标

主要结局

PheT:HOPhe ratio

时间窗: Up to 6 hours

A multiple regression analysis will be performed including explanatory variables such as lesion status, presence/absence of COPD or asbestos, duration of smoking, smoking intensity, age, and gender.

Correlation of deuterated phenanthrene tetraol level and PheT:HOPhe ratio with the presence of bronchoepithelial metaplasia and/or dysplasia

时间窗: Up to 6 hours

A multiple regression analysis will be performed including explanatory variables such as lesion status, presence/absence of COPD or asbestos, duration of smoking, smoking intensity, age, and gender.

Urinary deuterated phenanthrene tetraol level

时间窗: Up to 6 hours

A multiple regression analysis will be performed including explanatory variables such as lesion status, presence/absence of chronic obstructive pulmonary disease (COPD) or asbestos, duration of smoking, smoking intensity, age, and gender.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Deuterated Phenanthrene Tetraol in Smokers Who Are... | 临床试验